Intelligent Insulin Pens Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064655
  • May 2021
  • Medical Devices
  • 115 Pages
The Intelligent Insulin Pens Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Novo Nordisk, Companion Medical, Eli Lilly and Company, Diamesco Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt. Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co. Ltd., Bigfoot biomedica, njexUK, mith\'s Medical, IPRO Medical Corporation, iocorp, ERLIN-CHEMIE, iabnex
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Intelligent Insulin Pens market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Intelligent Insulin Pens market is expected to attain Pre COVID-19 levels by mid-2022.

Intelligent Insulin Pens Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Intelligent Insulin Pens market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Intelligent Insulin Pens Market Competitive and Premeditated Analysis
In the Intelligent Insulin Pens report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Intelligent Insulin Pens research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Intelligent Insulin Pens Market:
The Intelligent Insulin Pens market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Novo Nordisk, Companion Medical, Eli Lilly and Company, Diamesco Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt. Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co. Ltd., Bigfoot biomedica, njexUK, mith\'s Medical, IPRO Medical Corporation, iocorp, ERLIN-CHEMIE, iabnex

The Intelligent Insulin Pens market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Intelligent Insulin Pens Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Intelligent Insulin Pens market:
By Product
Smart Insulin Pen
Adaptors for Conventional Pen
Connectivity
Bluetooth
USB
Application
Type 1 Diabetes
Type 2 Diabetes
End Use
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings


Regional Analysis of the Intelligent Insulin Pens market:
The Intelligent Insulin Pens market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Intelligent Insulin Pens report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Intelligent Insulin Pens market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Intelligent Insulin Pens market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Intelligent Insulin Pens market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Intelligent Insulin Pens market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Intelligent Insulin Pens market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Intelligent Insulin Pens market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Intelligent Insulin Pens market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Intelligent Insulin Pens market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Novo Nordisk
  • Companion Medical
  • Eli Lilly and Company
  • Diamesco Co. Ltd.
  • Emperra GmbH E-Health Technologies
  • Digital Medics Pvt. Ltd.
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Jiangsu Delfu medical device Co. Ltd.
  • Bigfoot biomedica
  • njexUK
  • mith's Medical
  • IPRO Medical Corporation
  • iocorp
  • ERLIN-CHEMIE
  • iabnex
  • Smart Insulin Pen
  • Adaptors for Conventional Pen
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Intelligent Insulin Pens Market Snapshot
          2.1.1. Global Intelligent Insulin Pens Market By Product,2019
               2.1.1.1.Smart Insulin Pen
               2.1.1.2.Adaptors for Conventional Pen
          2.1.2. Global Intelligent Insulin Pens Market By End Use,2019
               2.1.2.1.Hospitals
               2.1.2.2.Clinics
               2.1.2.3.Ambulatory Surgical Centers
               2.1.2.4.Home Care Settings
          2.1.3. Global Intelligent Insulin Pens Market By End-use,2019
          2.1.4. Global Intelligent Insulin Pens Market By Geography,2019

3. Global Intelligent Insulin Pens Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Intelligent Insulin Pens Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Intelligent Insulin Pens Market Size (US$), By Product, 2018 – 2028

5. Global Intelligent Insulin Pens Market Size (US$), By End Use, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End Use, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End Use, 2020
     5.2. Global Intelligent Insulin Pens Market Size (US$), By End Use, 2018 – 2028

6. Global Intelligent Insulin Pens Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Intelligent Insulin Pens Market Size (US$), By End-use, 2018 – 2028

7. Global Intelligent Insulin Pens Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Intelligent Insulin Pens Market Analysis, 2018 – 2028 
          7.2.1. North America Intelligent Insulin Pens Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Intelligent Insulin Pens Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Intelligent Insulin Pens Market Size (US$), By End Use, 2018 – 2028
          7.2.4. North America Intelligent Insulin Pens Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Intelligent Insulin Pens Market Analysis, 2018 – 2028 
          7.3.1.  Europe Intelligent Insulin Pens Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Intelligent Insulin Pens Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Intelligent Insulin Pens Market Size (US$), By End Use, 2018 – 2028
          7.3.4. Europe Intelligent Insulin Pens Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Intelligent Insulin Pens Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Intelligent Insulin Pens Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Intelligent Insulin Pens Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Intelligent Insulin Pens Market Size (US$), By End Use, 2018 – 2028
          7.4.4. Asia Pacific Intelligent Insulin Pens Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Intelligent Insulin Pens Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Intelligent Insulin Pens Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Intelligent Insulin Pens Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Intelligent Insulin Pens Market Size (US$), By End Use, 2018 – 2028
          7.5.4. Latin America Intelligent Insulin Pens Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Intelligent Insulin Pens Market Analysis, 2018 – 2028 
          7.6.1.  MEA Intelligent Insulin Pens Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Intelligent Insulin Pens Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Intelligent Insulin Pens Market Size (US$), By End Use, 2018 – 2028
          7.6.4. MEA Intelligent Insulin Pens Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Intelligent Insulin Pens Providers
        8.4.1 Novo Nordisk
                8.4.1.1 Business Description
                8.4.1.2 Novo Nordisk Geographic Operations
                8.4.1.3 Novo Nordisk Financial Information
                8.4.1.4 Novo Nordisk Product Positions/Portfolio
                8.4.1.5 Novo Nordisk Key Developments
        8.4.2 Companion Medical
                8.4.2.1 Business Description
                8.4.2.2 Companion Medical Geographic Operations
                8.4.2.3 Companion Medical Financial Information
                8.4.2.4 Companion Medical Product Positions/Portfolio
                8.4.2.5 Companion Medical Key Developments
        8.4.3 Eli Lilly and Company
                8.4.3.1 Business Description
                8.4.3.2 Eli Lilly and Company Geographic Operations
                8.4.3.3 Eli Lilly and Company Financial Information
                8.4.3.4 Eli Lilly and Company Product Positions/Portfolio
                8.4.3.5 Eli Lilly and Company Key Developments
        8.4.4 Diamesco Co. Ltd.
                8.4.4.1 Business Description
                8.4.4.2 Diamesco Co. Ltd. Geographic Operations
                8.4.4.3 Diamesco Co. Ltd. Financial Information
                8.4.4.4 Diamesco Co. Ltd. Product Positions/Portfolio
                8.4.4.5 Diamesco Co. Ltd. Key Developments
        8.4.5 Emperra GmbH E-Health Technologies
                8.4.5.1 Business Description
                8.4.5.2 Emperra GmbH E-Health Technologies Geographic Operations
                8.4.5.3 Emperra GmbH E-Health Technologies Financial Information
                8.4.5.4 Emperra GmbH E-Health Technologies Product Positions/Portfolio
                8.4.5.5 Emperra GmbH E-Health Technologies Key Developments
        8.4.6 Digital Medics Pvt. Ltd.
                8.4.6.1 Business Description
                8.4.6.2 Digital Medics Pvt. Ltd. Geographic Operations
                8.4.6.3 Digital Medics Pvt. Ltd. Financial Information
                8.4.6.4 Digital Medics Pvt. Ltd. Product Positions/Portfolio
                8.4.6.5 Digital Medics Pvt. Ltd. Key Developments
        8.4.7 F. Hoffmann-La Roche AG
                8.4.7.1 Business Description
                8.4.7.2 F. Hoffmann-La Roche AG Geographic Operations
                8.4.7.3 F. Hoffmann-La Roche AG Financial Information
                8.4.7.4 F. Hoffmann-La Roche AG Product Positions/Portfolio
                8.4.7.5 F. Hoffmann-La Roche AG Key Developments
        8.4.8 Insulet Corporation
                8.4.8.1 Business Description
                8.4.8.2 Insulet Corporation Geographic Operations
                8.4.8.3 Insulet Corporation Financial Information
                8.4.8.4 Insulet Corporation Product Positions/Portfolio
                8.4.8.5 Insulet Corporation Key Developments
        8.4.9 Jiangsu Delfu medical device Co. Ltd.
                8.4.9.1 Business Description
                8.4.9.2 Jiangsu Delfu medical device Co. Ltd. Geographic Operations
                8.4.9.3 Jiangsu Delfu medical device Co. Ltd. Financial Information
                8.4.9.4 Jiangsu Delfu medical device Co. Ltd. Product Positions/Portfolio
                8.4.9.5 Jiangsu Delfu medical device Co. Ltd. Key Developments
        8.4.10 Bigfoot biomedica
                8.4.10.1 Business Description
                8.4.10.2 Bigfoot biomedica Geographic Operations
                8.4.10.3 Bigfoot biomedica Financial Information
                8.4.10.4 Bigfoot biomedica Product Positions/Portfolio
                8.4.10.5 Bigfoot biomedica Key Developments
        8.4.11 njexUK
                8.4.11.1 Business Description
                8.4.11.2 njexUK Geographic Operations
                8.4.11.3 njexUK Financial Information
                8.4.11.4 njexUK Product Positions/Portfolio
                8.4.11.5 njexUK Key Developments
        8.4.12 mith's Medical
                8.4.12.1 Business Description
                8.4.12.2 mith's Medical Geographic Operations
                8.4.12.3 mith's Medical Financial Information
                8.4.12.4 mith's Medical Product Positions/Portfolio
                8.4.12.5 mith's Medical Key Developments
        8.4.13 IPRO Medical Corporation
                8.4.13.1 Business Description
                8.4.13.2 IPRO Medical Corporation Geographic Operations
                8.4.13.3 IPRO Medical Corporation Financial Information
                8.4.13.4 IPRO Medical Corporation Product Positions/Portfolio
                8.4.13.5 IPRO Medical Corporation Key Developments
        8.4.14 iocorp
                8.4.14.1 Business Description
                8.4.14.2 iocorp Geographic Operations
                8.4.14.3 iocorp Financial Information
                8.4.14.4 iocorp Product Positions/Portfolio
                8.4.14.5 iocorp Key Developments
        8.4.15 ERLIN-CHEMIE
                8.4.15.1 Business Description
                8.4.15.2 ERLIN-CHEMIE Geographic Operations
                8.4.15.3 ERLIN-CHEMIE Financial Information
                8.4.15.4 ERLIN-CHEMIE Product Positions/Portfolio
                8.4.15.5 ERLIN-CHEMIE Key Developments
        8.4.16 iabnex
                8.4.16.1 Business Description
                8.4.16.2 iabnex Geographic Operations
                8.4.16.3 iabnex Financial Information
                8.4.16.4 iabnex Product Positions/Portfolio
                8.4.16.5 iabnex Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Intelligent Insulin Pens Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Intelligent Insulin Pens Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Intelligent Insulin Pens Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Intelligent Insulin Pens Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Intelligent Insulin Pens Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Intelligent Insulin Pens Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Intelligent Insulin Pens Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Intelligent Insulin Pens Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Intelligent Insulin Pens Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Intelligent Insulin Pens Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Intelligent Insulin Pens Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Intelligent Insulin Pens Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Intelligent Insulin Pens Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Intelligent Insulin Pens Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Intelligent Insulin Pens Market Revenue, By End Use, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Intelligent Insulin Pens Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Intelligent Insulin Pens: Market Segmentation 
FIG. 2 Global Intelligent Insulin Pens Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Intelligent Insulin Pens Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Intelligent Insulin Pens Market, By End Use, 2019 (US$ Mn) 
FIG. 6 Global Intelligent Insulin Pens Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Intelligent Insulin Pens Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Intelligent Insulin Pens Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Intelligent Insulin Pens Providers, 2019
FIG. 11 Global Intelligent Insulin Pens Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Intelligent Insulin Pens Market Revenue Contribution, By End Use, 2019 & 2028 (Value %) 
FIG. 13 Global Intelligent Insulin Pens Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Intelligent Insulin Pens Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Intelligent Insulin Pens Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Intelligent Insulin Pens Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Intelligent Insulin Pens Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Intelligent Insulin Pens Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Intelligent Insulin Pens market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Intelligent Insulin Pens Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Intelligent Insulin Pens Market Value, By Segment1, 2018 – 2028
TABLE  North America Intelligent Insulin Pens Market Value, By Segment2, 2018 – 2028
TABLE  North America Intelligent Insulin Pens Market Value, By Country, 2018 – 2028
TABLE  Europe Intelligent Insulin Pens Market Value, By Segment1, 2018 – 2028
TABLE  Europe Intelligent Insulin Pens Market Value, By Segment2, 2018 – 2028
TABLE  Europe Intelligent Insulin Pens Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Intelligent Insulin Pens Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Intelligent Insulin Pens Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Intelligent Insulin Pens Market Value, By Country, 2018 – 2028
TABLE  Latin America Intelligent Insulin Pens Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Intelligent Insulin Pens Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Intelligent Insulin Pens Market Value, By Country, 2018 – 2028
TABLE  MEA Intelligent Insulin Pens Market Value, By Segment1, 2018 – 2028
TABLE  MEA Intelligent Insulin Pens Market Value, By Segment2, 2018 – 2028
TABLE  MEA Intelligent Insulin Pens Market Value, By Country, 2018 – 2028
TABLE  Novo Nordisk: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Companion Medical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Diamesco Co. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Emperra GmbH E-Health Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Digital Medics Pvt. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Insulet Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Jiangsu Delfu medical device Co. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bigfoot biomedica: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  njexUK: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  mith's Medical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  IPRO Medical Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  iocorp: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ERLIN-CHEMIE: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  iabnex: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Intelligent Insulin Pens Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Intelligent Insulin Pens Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Intelligent Insulin Pens Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Intelligent Insulin Pens Market, By Geography, 2019 (US$ Mn)
FIG.  Global Intelligent Insulin Pens Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Intelligent Insulin Pens Providers, 2016
FIG.  Global Intelligent Insulin Pens Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Adaptors for Conventional Pen Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Intelligent Insulin Pens Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ambulatory Surgical Centers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Home Care Settings Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Intelligent Insulin Pens Market Value, 2018 – 2028, (US$ Mn)